Company Filing History:
Years Active: 2010-2014
Title: Sven-Börje Andersson: Innovator in Pharmaceutical Formulations
Introduction
Sven-Börje Andersson is a notable inventor based in Okakra, Sweden. He has made significant contributions to the field of pharmaceutical formulations, particularly in the administration of nicotine for therapeutic purposes. With a total of 2 patents, his work focuses on innovative methods to aid in the treatment of tobacco addiction.
Latest Patents
Andersson's latest patents include formulations that provide liquid pharmaceutical solutions comprising nicotine for administration primarily to the lungs. These formulations are designed to be acidified and/or alkalized through buffering and/or pH regulation, ensuring a rapid increase of nicotine levels in the arterial blood of a subject after administration. The preferred method of administration involves spraying an aerosol into the oral cavity, allowing for effective distribution into the lungs. Additionally, methods for manufacturing these formulations are disclosed, along with their therapeutic uses, particularly in treating tobacco addiction.
Career Highlights
Throughout his career, Sven-Börje Andersson has been associated with McNeil AB, where he has contributed to the development of innovative pharmaceutical products. His expertise in nicotine formulations has positioned him as a key figure in the fight against tobacco addiction.
Collaborations
Andersson has worked alongside notable colleagues, including Mark Peter Warchol and Folke Morén, contributing to a collaborative environment that fosters innovation in pharmaceutical research.
Conclusion
Sven-Börje Andersson's work in pharmaceutical formulations exemplifies the intersection of innovation and healthcare. His contributions are vital in addressing the challenges of tobacco addiction through effective nicotine delivery systems.